| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Myomo is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. Co. develops and markets the MyoPro product line. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis. The orthosis is a rigid brace used for the purpose of supporting a patient's weak or paralyzed arm to enable and help improve functional activities of daily living in the home and community. Co.'s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
50,000 |
100,000 |
342,899 |
751,898 |
| Total Buy Value |
$175,000 |
$350,000 |
$647,497 |
$782,457 |
| Total People Bought |
1 |
1 |
5 |
6 |
| Total Buy Transactions |
1 |
2 |
9 |
13 |
| Total Shares Sold |
35,426 |
35,426 |
73,753 |
80,894 |
| Total Sell Value |
$130,839 |
$130,839 |
$130,839 |
$143,057 |
| Total People Sold |
1 |
1 |
2 |
2 |
| Total Sell Transactions |
1 |
1 |
4 |
5 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mitchell Micah |
Chief Commercial Officer |
• – – |
2018-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Crowley Thomas Aloysius Jr. |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,966 |
13,773 |
|
- |
|
| Knapp Amy K. |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,966 |
13,773 |
|
- |
|
| Sanghi Steve |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,966 |
562,286 |
|
- |
|
| Kirk Thomas F |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,966 |
105,423 |
|
- |
|
| Kirk Thomas F |
Director |
– • – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,807 |
95,457 |
|
- |
|
| Crowley Thomas Aloysius Jr. |
Director |
– • – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,807 |
3,807 |
|
- |
|
| Sanghi Steve |
Director |
– • – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,807 |
552,320 |
|
- |
|
| Knapp Amy K. |
Director |
– • – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,807 |
3,807 |
|
- |
|
| Naft Jonathan |
VP, General Manager |
• – – |
2018-01-02 |
4/A |
D |
$3.65 |
$10,848 |
D/D |
(2,972) |
79,361 |
|
- |
|
| Goldwasser Ralph A |
Chief Financial Officer |
• – – |
2018-01-02 |
4/A |
D |
$3.65 |
$11,326 |
D/D |
(3,103) |
45,730 |
|
- |
|
| Green Brandon M |
Chief Medical Officer |
• – – |
2018-01-02 |
4/A |
D |
$3.65 |
$5,070 |
D/D |
(1,389) |
2,309 |
|
- |
|
| Gudonis Paul R |
Chief Executive Officer |
• • – |
2018-01-02 |
4/A |
D |
$3.65 |
$13,593 |
D/D |
(3,724) |
450,246 |
|
- |
|
| Conneighton Cliff |
Chief Marketing Officer |
• – – |
2018-01-02 |
4/A |
D |
$3.65 |
$1,956 |
D/D |
(536) |
36,295 |
|
- |
|
| Mendelsohn Davie |
VP, Sales |
• – – |
2018-01-02 |
4/A |
D |
$3.65 |
$9,037 |
D/D |
(2,476) |
21,804 |
|
- |
|
| Green Brandon M |
Chief Medical Officer |
• – – |
2018-01-02 |
4 |
D |
$3.65 |
$5,731 |
D/D |
(1,570) |
2,129 |
|
- |
|
| Green Brandon M |
Chief Medical Officer |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,698 |
3,698 |
|
- |
|
| Gudonis Paul R |
Chief Executive Officer |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
32,363 |
472,244 |
|
- |
|
| Gudonis Paul R |
Chief Executive Officer |
• – – |
2018-01-02 |
4 |
D |
$3.65 |
$15,425 |
D/D |
(4,226) |
449,744 |
|
- |
|
| Conneighton Cliff |
Chief Marketing Officer |
• – – |
2018-01-02 |
4 |
D |
$3.65 |
$2,121 |
D/D |
(581) |
36,250 |
|
- |
|
| Conneighton Cliff |
Chief Marketing Officer |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,643 |
36,831 |
|
- |
|
| Mendelsohn Davie |
VP, Sales |
• – – |
2018-01-02 |
4 |
D |
$3.65 |
$10,738 |
D/D |
(2,942) |
21,338 |
|
- |
|
| Mendelsohn Davie |
VP, Sales |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,575 |
24,280 |
|
- |
|
| Naft Jonathan |
VP, General Manager |
• – – |
2018-01-02 |
4 |
D |
$3.65 |
$13,009 |
D/D |
(3,564) |
78,769 |
|
- |
|
| Naft Jonathan |
VP, General Manager |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,219 |
82,333 |
|
- |
|
199 Records found
|
|
Page 7 of 8 |
|
|
